4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-002284
President and CEO sold 18,333 shares at an average $19.43 ($356,288)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-01-02 | Sale | −5,050 | $19.42 | $98,071 | 2,665,921 | I |
| Watts Ryan J. President and CEO | 2019-01-02 | Sale | −1,000 | $20.24 | $20,240 | 2,664,921 | I |
| Watts Ryan J. President and CEO | 2019-01-03 | Sale | −6,050 | $18.89 | $114,285 | 2,658,871 | I |
| Watts Ryan J. President and CEO | 2019-01-04 | Sale | −1,300 | $19.18 | $24,934 | 2,657,571 | I |
| Watts Ryan J. President and CEO | 2019-01-04 | Sale | −4,933 | $20.02 | $98,759 | 2,652,638 | I |
| Open-market sales · 18,333 sh · avg $19.43 · $356,288 | |||||||
Loading xslF345X03/doc4.xml…